707 related articles for article (PubMed ID: 9137102)
1. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.
Ren ZP; Ahmadian A; Pontén F; Nistér M; Berg C; Lundeberg J; Uhlén M; Pontén J
Am J Pathol; 1997 May; 150(5):1791-803. PubMed ID: 9137102
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.
Ren ZP; Hedrum A; Pontén F; Nistér M; Ahmadian A; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1996 Feb; 12(4):765-73. PubMed ID: 8632898
[TBL] [Abstract][Full Text] [Related]
3. Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.
Ahmadian A; Ren ZP; Williams C; Pontén F; Odeberg J; Pontén J; Uhlén M; Lundeberg J
Oncogene; 1998 Oct; 17(14):1837-43. PubMed ID: 9778050
[TBL] [Abstract][Full Text] [Related]
4. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
Shahnavaz SA; Regezi JA; Bradley G; Dubé ID; Jordan RC
J Pathol; 2000 Mar; 190(4):417-22. PubMed ID: 10699989
[TBL] [Abstract][Full Text] [Related]
6. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
Ren ZP; Pontén F; Nistér M; Pontén J
Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
[TBL] [Abstract][Full Text] [Related]
7. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology in basal cell cancer with p53 as a genetic marker.
Pontén F; Berg C; Ahmadian A; Ren ZP; Nistér M; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1997 Aug; 15(9):1059-67. PubMed ID: 9285560
[TBL] [Abstract][Full Text] [Related]
9. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
10. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.
Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH
Cancer Res; 2005 May; 65(9):3577-85. PubMed ID: 15867351
[TBL] [Abstract][Full Text] [Related]
11. Sunburn and p53 in the onset of skin cancer.
Ziegler A; Jonason AS; Leffell DJ; Simon JA; Sharma HW; Kimmelman J; Remington L; Jacks T; Brash DE
Nature; 1994 Dec 22-29; 372(6508):773-6. PubMed ID: 7997263
[TBL] [Abstract][Full Text] [Related]
12. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
de Graaf YG; Rebel H; Elghalbzouri A; Cramers P; Nellen RG; Willemze R; Bouwes Bavinck JN; de Gruijl FR
Exp Dermatol; 2008 Apr; 17(4):349-55. PubMed ID: 17979968
[TBL] [Abstract][Full Text] [Related]
13. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi G; Miozzo M; Donghi R; Pilotti S; Cariani CT; Pastorino U; Della Porta G; Pierotti MA
Cancer Res; 1992 Nov; 52(21):6079-82. PubMed ID: 1394234
[TBL] [Abstract][Full Text] [Related]
14. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F
Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
16. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
17. Roles of the transcription factor p53 in keratinocyte carcinomas.
Brash DE
Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
19. Skin precancer.
Brash DE; Pontén J
Cancer Surv; 1998; 32():69-113. PubMed ID: 10489624
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]